Validation experiment designed to validate causal mechanisms targeting CD2AP in male mice. Primary outcome: partial rescue of vascular impairments in male mice only
Pharmacological intervention study testing whether blocking endothelin-1 receptor A signaling can rescue vascular impairments in CD2AP mutant mice, with sex-specific analysis. This therapeutic experiment administered endothelin-1 receptor A antagonists to mice with reduced endothelial CD2AP and assessed whether this treatment could restore normal cerebrovascular function. The study revealed male-specific rescue effects, suggesting sex-dependent mechanisms in CD2AP-related vascular dysfunction.
endothelin-1 receptor A antagonist treatment followed by cerebrovascular function assessment
sex-specific rescue of vascular defects
improved vascular function in treated male mice
No related hypotheses
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.